[unable to retrieve full-text content]
The likes of Pfizer and Lilly have announced the halting of research in light of Moscow’s offensive against Ukraine Several major international pharmaceutical companies including Pfizer, Lilly and Sanofi have issued statements, announcing the suspension of new clinical trials in Russia in light of its military campaign against Ukraine.
The stalled effort is actually “some kind of preparatory operation,” the Ukrainian Defense Minister insists Expected results from Kiev’s ongoing counteroffensive against Russia have been “overestimated,” Ukraine’s Defense Minister Alexey Reznikov has claimed. The offensive by Ukrainian forces should be treated as “some kind of preparatory operation” rather than a decisive battle, he added.